Election Day, Continued: Leon Cooperman, Uber CEO, & Arthur Brooks
Legendary investor Leon Cooperman explains his approach to markets amid the ongoing Presidential vote and the Federal Reserve’s approach to stabilizing the economy. The billionaire explains his person...
6 Marras 202037min
“It’s Got to End at Some Point, for the Good of the Country”
As 2020 election results trickle in, Al Gore’s running mate former Senator Joe Lieberman reflects on the 34 controversial days between Election Day in 2000 and Gore’s final concession. His lessons fro...
5 Marras 202035min
He’s a Political Force: Barry Diller & David Rubenstein, the Morning After
As votes are counted across the country, David Rubenstein, co-founder and co-executive chairman of The Carlyle Group, expects market jitters to continue until a clear winner emerges. He and IAC Chairm...
4 Marras 202030min
Election Day 2020: The United States of Anxiety
Election Day 2020 is finally here. At this culmination of America’s anxieties, former Facebook Chief Security Officer Alex Stamos discusses social media’s strategies and obligations to curb misinforma...
3 Marras 202035min
Counting on Confidence: Vaccines with Dr. Atul Gawande & Investor Sentiment Beyond Election Day
Dr. Atul Gawande, Chairman of Haven, surgeon, and staff writer for The New Yorker, shares his expectations for coronavirus vaccine supply and American confidence in preventative drugs. CNBC’s Steve Li...
30 Loka 202032min
Vaccines & Voting with Merck CEO; Tech & Politics on the Hill
Ken Frazier, CEO of drug maker Merck, maps out his timeline for a coronavirus vaccine as cases continue to rise around the world. In a conversation with Yale School of Management’s Jeff Sonnenfeld, Fr...
29 Loka 202031min
Robinhood CEO Vlad Tenev: The Rise of the Retail Investor
Robinhood, the trading app that took young people and financiers by storm, now boasts 13 million user accounts. Its zero-commission trading model prompted an overhaul of the online brokerage ecosystem...
28 Loka 202029min
Eli Lilly CEO on Antibody Trial’s Finish; CEOs Get Out the Vote
The National Institutes of Health has halted one of Eli Lilly’s coronavirus antibody trials, having found that the combination of Lilly’s antibody drug and Gilead’s remdesivir does not result in a mar...
27 Loka 202029min
